A unique range of integrated early stage development services to support biopharmaceutical drug development.
Cell Line Development
Upstream Process Development
Physicochemical & Structural Analyses
Cell Bank Manufacturing
Cell Bank Characterisation
GMP Lot Release
Solutions through experience
This extensive suite of services combines Cellca’s cell line and upstream process development expertise with BioOutsource’s bioanalytical and biosafety contract testing expertise to support customers from cell line development, through product manufacture and release. Broadening Sartorius Stedim Biotech’s portfolio of products, technologies and services and enabling a comprehensive “Total Solution” to support our clients’ drug development activities.
Benefit from the combined experience of Cellca, BioOutsource and Sartorius Stedim Biotech to efficiently advance your drug candidates quickly from early stage development through to commercialisation.
Accelerated drug development
Based on its unparalleled global experience working to support biological drug development, BioOutsource and Cellca lead the way in preclinical development. Through our robust platforms, off-the-shelf assays and commitment to providing a total solution, Sartorius Stedim Biotech can accelerate your drug’s development.
BioOutsource and Cellca have industry leading expertise in supporting biosimilar drug development. Collectively we have worked with over 50 biosimilar developers across 12 countries, totaling 230 biosimilar projects. Benefit from our combined experience and integrated services to further mitigate risks and select optimal biosimilar clones. Find out more.
Our service offering is underpinned by our commitment to delivering excellent customer service, navigating our customers through the complexities of the drug development cycle and enabling them to make informed data-driven decisions. Our client management team provide an intimate customer experience and ensure your project is managed efficiently and delivered on time. Effective communication is key to success, and our team understand that a transparent, proactive approach to customer service will ensure the delivery of a truly differentiated solution.
Contact our experts today to discuss your drug development programmes.
Goettingen, GER | Glasgow, UK – May 4, 2017: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of a full range of chemistry testing services. Offered by its subsidiary BioOutsource, they characterize the physicochemical properties and structural attributes of therapeutic monoclonal antibodies (mAbs). The service platform methods have More
On Wednesday 19th April 2017, Sartorius Stedim BioOutsource were named as Scottish Life Sciences Company of the Year at the Made in Scotland awards. The annual Made in Scotland awards rewards Scottish companies that have innovative products and services and have subsequently found success domestically and internationally. We were delighted to be announced as the winner More
• Biopharma provider purchases property in Science Park III of Ulm • Laboratory and office facility to be constructed on the site by 2019 Göttingen/Laupheim, December 14, 2016 – Sartorius Stedim Cellca based near Ulm in southern Germany, continues on the growth track. At the end of November, the company in its eleventh year since More